Overview

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
The HYGIA study was designed to investigate prospectively 1. the prognostic value of ambulatory blood pressure (BP) monitoring among subjects primarily evaluated at primary care settings 2. the impact of changes in ambulatory BP during follow-up in cardiovascular, cerebrovascular, metabolic, and renal risk in hypertensive patients 3. the influence of circadian time of treatment in cardiovascular, cerebrovascular, metabolic, and renal risk in hypertensive patients 4. the prevalence of an altered BP profile as a function of antihypertensive treatment, circadian time of treatment, age, and presence of diabetes, among other factors.
Phase:
Phase 4
Details
Lead Sponsor:
University of Vigo
Collaborator:
Servicio Gallego de Salud
Treatments:
Amlodipine
Antihypertensive Agents
Atenolol
Candesartan
Candesartan cilexetil
Carvedilol
Doxazosin
Enalapril
Enalaprilat
Irbesartan
Lercanidipine
Lisinopril
Manidipine
Olmesartan
Olmesartan Medoxomil
Quinapril
Ramipril
Telmisartan
Valsartan